LFR
DMK

Lehman Financial Resources’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Lehman Financial Resources’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-14
Closed -$3K – 382
2015
Q3 		$3K Hold
14
– – ﹤0.01% 400
2015
Q2 		$4K Hold
14
– – ﹤0.01% 377
2015
Q1 		$4K Buy
+14
New +$6.05K ﹤0.01% 369

Other funds holding DMK

SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lehman Financial Resources's DMK Position: Q4 2015 in Review

Lehman Financial Resources sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q4 2015, closing a stake of 14 shares — an estimated $3K sold.

Lehman Financial Resources first reported a position in DMK in Q1 2015 and held it in 3 quarters. The position peaked at $4K in Q2 2015. 25 funds tracked by Wall St. Rank hold DMK as of Q4 2015.

  • Lehman Financial Resources reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q4 2015 after selling out during the quarter.
  • Lehman Financial Resources sold 14 DMK Pharmaceuticals Corporation Common Stock shares in Q4 2015, an estimated $3K.
  • Lehman Financial Resources first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2015 and held it in 3 quarters.
  • Lehman Financial Resources's DMK Pharmaceuticals Corporation Common Stock position peaked at $4K in Q2 2015.
  • 25 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q4 2015.

Based on Lehman Financial Resources's 13F filing for Q4 2015, filed 17 Feb 2016.